These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12552793)

  • 1. [Progress in the controlled release systems of hirudin].
    Li T; Wan C; Li Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1998 Dec; 15(4):419-23. PubMed ID: 12552793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of experimental coronary thrombosis by hirudin.
    Bucha E; Nowak G; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):52-8. PubMed ID: 2459032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple-coated stents (Hirudin/Iloprost/Paclitaxel): an in vitro approach for characterizing the antiproliferative potential of each individual compound.
    Voisard R; Stemberger A; Baur R; Herter T; Hähnel I; Resch A; Seliger C; Hemmer W; Hannekum A; Hombach V; Alt E
    Int J Cardiol; 2005 Jul; 102(3):425-33. PubMed ID: 16004887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization.
    Liu Y; Lu WL; Wang JC; Zhang X; Zhang H; Wang XQ; Zhou TY; Zhang Q
    J Control Release; 2007 Feb; 117(3):387-95. PubMed ID: 17207884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of recombinant hirudin.
    Nowak G
    Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach for local intravascular drug delivery. Iontophoretic balloon.
    Fernández-Ortiz A; Meyer BJ; Mailhac A; Falk E; Badimon L; Fallon JT; Fuster V; Chesebro JH; Badimon JJ
    Circulation; 1994 Apr; 89(4):1518-22. PubMed ID: 8149516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hirudins--new antithrombotic agent.
    Katira R; Puri VK
    J Assoc Physicians India; 1994 Mar; 42(3):240-1. PubMed ID: 7860517
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the TCT: questions surround antithrombotic therapy in coronary DES implantation.
    White J
    J Interv Cardiol; 2006 Jun; 19(3):232-5. PubMed ID: 16724964
    [No Abstract]   [Full Text] [Related]  

  • 11. [Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents].
    Stenestrand U
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2838-9. PubMed ID: 17128915
    [No Abstract]   [Full Text] [Related]  

  • 12. Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudin.
    Carr CS; Rayner A; Ponte J; Desai JB
    Ann Thorac Surg; 2005 Feb; 79(2):696-8. PubMed ID: 15680867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-eluting stents can increase the risk of late stent thrombosis].
    Skyttberg N; Linder R; Carlsson J
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing subacute stent thrombosis--is there a role for heparin-coated stents?
    Carrozza JP
    J Invasive Cardiol; 2003 Aug; 15(8):442-3. PubMed ID: 12890873
    [No Abstract]   [Full Text] [Related]  

  • 15. Local catheter-based delivery of antithrombotic or antiproliferative drugs: a new concept for prevention of restenosis.
    Herdeg C; Goehring-Frischholz K; Zuern C; Geisler T; Hartmann U; Hoevelborn T; Haase KK; Gawaz M
    Thromb Res; 2008; 123(2):236-43. PubMed ID: 18452977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Absorption of recombinant hirudin in rats GI tract].
    Yan XY; Zhang XN; Zhang Q
    Yao Xue Xue Bao; 2004 Jan; 39(1):77-80. PubMed ID: 15127588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive stent coatings in the drug-eluting era.
    Menown I; Lowe R; Penn I
    J Invasive Cardiol; 2005 Apr; 17(4):222-8. PubMed ID: 15831978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive balloon postdilatation after stent deployment: is it still necessary with drug-eluting stents?
    Brodie BR
    J Interv Cardiol; 2006 Feb; 19(1):43-50. PubMed ID: 16483339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.